US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 12.260
  • +0.050+0.41%
Close Feb 14 16:00 ET
  • 12.500
  • +0.240+1.96%
Post 20:01 ET
1.24BMarket Cap-12.64P/E (TTM)

Day One Biopharmaceuticals Key Stats

Day One Biopharmaceuticals Q4 2024 Estimates Date

Currency:USDFeb 25, 2025

Estimate YoY
Revenue
27.79M
--
EPS
-0.36
+43.37%
Strong Buy

Feb 10, 2025

Day One Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 33.150M--
Feb 25, 20252024/Q4-- / 27.790M--
Oct 30, 20242024/Q393.761M / 28.451M--
Jul 30, 20242024/Q28.192M / 912.220K--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 33.150M--
Feb 25, 20252024/Q4-- / 27.790M--
Oct 30, 20242024/Q393.761M / 28.451M--
Jul 30, 20242024/Q28.192M / 912.220K--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Day One Biopharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 10, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data